OOIR: Observatory of International Research

Papers

(The TQCC of Seminars in Respiratory and Critical Care Medicine is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-07-01 to 2026-07-01.)

Article	Citations
Monographic Issue on Pulmonary Hypertension: Medical and Interventional Treatment for Chronic Thromboembolic Pulmonary Hypertension	64
Sleep, Circadian Rhythms, and Lung Cancer	43
Pneumonia after Solid Organ Transplantation	43
State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens	33
Impact of Digital Technologies on Clinical Care for Adults with Cystic Fibrosis	32
Diffuse Alveolar Hemorrhage	30
	22
Factors Influencing Glucocorticoid Treatment Response: Mechanism-Based Strategies to Overcome Glucocorticoid Resistance and Restore GRα Function	21
Nonmalignant Pleural Effusions	21
Lung Transplant for Chronic Obstructive Pulmonary Disease	21
Chronic Obstructive Pulmonary Disease and Work: The Continuing Narrative	21
Advances in the Understanding and Management of Chronic Obstructive Pulmonary Disease	21
Prevention of Aspiration: Oral Care, Antibiotics, Others	19
Indwelling Pleural Catheter: Management of Complications	19
Impact of Marijuana Use on Lung Health	18
Imaging in the Intensive Care Unit	18
	17
COVID-19-Related Pleural Diseases	16
The Oral–Lung Microbiome Axis in Connective Tissue Disease-Related Interstitial Lung Disease	16
Management of Dyspnea in Patients with Neuromuscular Disorders	16
Deployment-Related Respiratory Disease: Where Are We?	14
Antibiotic Strategies for Severe Community-Acquired Pneumonia	13
Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis	12
Chronic Pulmonary Aspergillosis: Clinical Presentation and Management	12
Diagnostic Approach to Interstitial Lung Diseases Associated with Connective Tissue Diseases	11

Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease Overlap Syndrome	11
Update on Sepsis Epidemiology in the Era of COVID-19	11
Microbiologic Diagnosis of Respiratory Infections in Critically Ill Immunocompromised Patients	11
Management of Pulmonary Hypertension Associated with Chronic Lung Disease	11
Tissue Perfusion and Diffusion and Cellular Respiration: Transport and Utilization of Oxygen	11
How to Survive Sepsis: Patient Testimonial	10
Definition and Epidemiology of Sepsis	10
Lung Cancer Progress and Promise: Shaping the Future of Care	10
Nocturnal Hypoxemia in Respiratory Medicine: Pathophysiology, Measurement, and Association with Outcomes	10
	10
Pulmonary Physiology and Medicine of Diving	10
Lung Cancer in Special Populations	9
Updates in Lung Cancer Screening: A Decade of Evidence	9
Bronchoscopic Lung Volume Reduction: A Review	9
Survivorship Challenges and Supportive Care in Lung Cancer	9
Emerging Concepts in Fibroblast Biology and Progressive Pulmonary Fibrosis	9
Beyond the Lungs—Emerging Challenges in Adult Cystic Fibrosis Care	9
Blood Gas Transport: Implications for O2 and CO2 Exchange in Lungs and Tissues	9
Interstitial Lung Disease Associated with Systemic Sclerosis	8
Immunopathogenesis of Sarcoidosis	8
Pertussis Vaccination: The Challenges Ahead	8
Aspergillus and the Lung	8
Work-Related Sleep Disorders: Causes and Impacts	8
Community-Acquired Pneumonia: Postpandemic, Not Post-COVID-19	8
Clinical Features of COVID-19 and Differentiation from Other Causes of CAP	8
Peeling Back the Layers of the Bleomycin Model of Lung Fibrosis: Lessons Learned, Factors to Consider, and Future Directions	8
Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease	8
Corticosteroid Treatment in Septic Shock	8
Comorbid Insomnia and Sleep Apnea: From Research to Clinical Practice	8
Management of Acutely Decompensated Pulmonary Hypertension	8
Sleep and Circadian-Related Outcomes after Critical Illness	7
Severe Community-Acquired Pneumonia in Immunocompromised Patients	7
Arterial Blood Gases and Acid–Base Regulation	7
Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis	7
Severe Community-Acquired Pneumonia	7
Pathological Diagnosis of Pulmonary Aspergillosis	7
Glucocorticoid Treatment in Community-Acquired Pneumonia	7
“Long Haulers”	7